N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide

C15H26N4O — CID 62040266

IUPACN-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide
SMILESCc1[nH]ncc1CCCNC(=O)CCC1CCCNC1
InChIInChI=1S/C15H26N4O/c1-12-14(11-18-19-12)5-3-9-17-15(20)7-6-13-4-2-8-16-10-13/h11,13,16H,2-10H2,1H3,(H,17,20)(H,18,19)
InChIKeySCAHWSLWOFRJEB-UHFFFAOYSA-N
MW278.40 g/mol
LogP1.55
Rot. Bonds7

About N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide

N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide (PubChem CID 62040266) has the molecular formula C15H26N4O and a molecular weight of 278.40 g/mol. Its IUPAC name is N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide.

Molecular Properties

Compound NameN-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide
PubChem CID62040266
Molecular FormulaC15H26N4O
Molecular Weight278.40 g/mol
Exact Mass278.21
IUPAC NameN-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide
SMILESCc1[nH]ncc1CCCNC(=O)CCC1CCCNC1
InChIInChI=1S/C15H26N4O/c1-12-14(11-18-19-12)5-3-9-17-15(20)7-6-13-4-2-8-16-10-13/h11,13,16H,2-10H2,1H3,(H,17,20)(H,18,19)
InChIKeySCAHWSLWOFRJEB-UHFFFAOYSA-N
XLogP1.55
TPSA69.81 Ų
H-Bond Donors3
H-Bond Acceptors3
Rotatable Bonds7
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500278.40
LogP ≤ 51.55
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-cyclopentyl-N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]acetamide
CID 62037988
N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-2-ylpropanamide
CID 62211661
3-piperidin-3-yl-N-[3-(1H-1,2,4-triazol-5-yl)propyl]propanamide
CID 64531341
3-piperidin-3-yl-N-[2-(1H-1,2,4-triazol-5-yl)ethyl]propanamide
CID 64530153
N-(3-cyclopentylpropyl)-3-piperidin-3-ylpropanamide
CID 106011682
3-(tert-butylamino)-N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]propanamide
CID 62039836
(3S,4S)-4-methyl-N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]pyrrolidine-3-carboxamide
CID 114084882
N-[2-(4-methyl-1,2,4-triazol-3-yl)ethyl]-3-piperidin-3-ylpropanamide
CID 63330246
2-(cyclobutylmethyl)-1-[3-(5-methyl-1H-pyrazol-4-yl)propyl]guanidine
CID 111042629
2-(1,4-diazepan-1-yl)-N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-2-oxoacetamide
CID 62040951
N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-2-(1H-pyrazol-5-yl)acetamide
CID 79004761
3-[3-(5-methyl-1H-pyrazol-4-yl)propylcarbamoylamino]propanoic acid
CID 62040744

Frequently Asked Questions

What is the IUPAC name of N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide?
The IUPAC name of N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide (CID 62040266) is N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide.
What is the SMILES notation for N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide?
The canonical SMILES for N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide is Cc1[nH]ncc1CCCNC(=O)CCC1CCCNC1.
What is the InChIKey of N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide?
The InChIKey is SCAHWSLWOFRJEB-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H26N4O/c1-12-14(11-18-19-12)5-3-9-17-15(20)7-6-13-4-2-8-16-10-13/h11,13,16H,2-10H2,1H3,(H,17,20)(H,18,19).
What are the key properties of N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide?
N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide has a molecular weight of 278.40 g/mol, XLogP of 1.55, 7 rotatable bonds, 3 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(5-methyl-1H-pyrazol-4-yl)propyl]-3-piperidin-3-ylpropanamide is sourced from PubChem (CID 62040266), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).